You are here » Home » Companies » Company Overview » Nutraplus India Ltd

Nutraplus India Ltd.

BSE: 524764 Sector: Health care
NSE: N.A. ISIN Code: INE230G01020
BSE 16:01 | 17 Sep 8.41 0.24
(2.94%)
OPEN

8.50

HIGH

8.55

LOW

8.10

NSE 05:30 | 01 Jan Nutraplus India Ltd
OPEN 8.50
PREVIOUS CLOSE 8.17
VOLUME 35926
52-Week high 23.80
52-Week low 6.70
P/E 9.04
Mkt Cap.(Rs cr) 29
Buy Price 8.41
Buy Qty 1.00
Sell Price 8.41
Sell Qty 2.00
OPEN 8.50
CLOSE 8.17
VOLUME 35926
52-Week high 23.80
52-Week low 6.70
P/E 9.04
Mkt Cap.(Rs cr) 29
Buy Price 8.41
Buy Qty 1.00
Sell Price 8.41
Sell Qty 2.00

Nutraplus India Ltd. (NUTRAPLUSINDIA) - Company History

Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123.66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC). The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide. During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs.